Back
Denali Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
DNLI
Denali Therapeutics, Inc.
Last Price:
$21.20
Seasonality Move:
-9.94%
7 Day Trial
ALL ACCESS PASS
$
7
Denali Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Denali Therapeutics, Inc. has on average historically risen by 9.9% based on the past 8 years of stock performance.
-
Denali Therapeutics, Inc. has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
-
Is Denali Therapeutics, Inc. Stock Undervalued?The current Denali Therapeutics, Inc. [DNLI] share price is $21.18. The Score for DNLI is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
DNLI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Denali Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Denali Therapeutics, Inc. has on average historically risen by 9.9% based on the past 8 years of stock performance.
Denali Therapeutics, Inc. Stock Rating
Sell
49
Denali Therapeutics, Inc. (DNLI)
is a Sell
Is Denali Therapeutics, Inc. overpriced?
-
Denali Therapeutics, Inc. has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
Denali Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
denalitherapeutics.com
52-Week Data
52-Week High:
23.77
52-Week Low:
10.57
Prediction Charts
Market Cap:
3.3B
Price in USD:
21.18
Volume:
1.4M
Beta:
1.52
Technical Analysis
SMA50:
19.03
SMA100:
18.01
SMA200:
16.16
52-Wk Change:
13.87%
Stock Predictions
-
Is Denali Therapeutics, Inc. stock public?Yes, Denali Therapeutics, Inc. is a publicly traded company.
-
What is the Denali Therapeutics, Inc. stock quote today?The Denali Therapeutics, Inc. stock price is 21.18 USD today.
-
How to buy Denali Therapeutics, Inc. stock online?You can buy Denali Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-9 | 21.20 | 20.84 | 21.20 | 20.16 |
| Feb-10 | 21.05 | 19.82 | 21.15 | 19.74 |
| Feb-11 | 19.91 | 19.69 | 20.00 | 18.66 |
| Feb-12 | 19.81 | 19.18 | 20.21 | 18.75 |
| Feb-13 | 19.24 | 18.77 | 20.12 | 18.61 |
| Feb-17 | 18.73 | 19.28 | 19.63 | 18.65 |
| Feb-18 | 19.01 | 19.23 | 20.01 | 19.00 |
| Feb-19 | 19.08 | 20.24 | 20.37 | 18.96 |
| Feb-20 | 20.00 | 20.19 | 20.51 | 19.69 |
| Feb-23 | 20.30 | 20.86 | 21.38 | 20.10 |
| Feb-24 | 20.86 | 21.43 | 21.56 | 20.48 |
| Feb-25 | 21.60 | 22.29 | 22.59 | 21.60 |
| Feb-26 | 22.20 | 21.42 | 22.40 | 21.00 |
| Feb-27 | 21.14 | 21.18 | 21.45 | 20.25 |
Denali Therapeutics, Inc. Earnings
Denali Therapeutics, Inc. Earnings Report: Per Share Denali Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Denali Therapeutics, Inc. Forecast Revenue Growth
Denali Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Denali Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.54 per share, and a decrease next year of $0.01 per share.
* Denali Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.